Recombination increases human immunodeficiency virus fitness, but not necessarily diversity

Journal of General Virology

Volumn 89, Issue 6, 2008, Pages 1467-1477

  Vijay, N N V ^a   Vasantika, ^a   Ajmani, Rahul ^b   Perelson, Alan S ^b   Dixit, Narendra M ^a  

^a INDIAN INSTITUTE OF SCIENCE   (India)

^b LOS ALAMOS NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COMPUTER SIMULATION; CONTROLLED STUDY; EFFECTIVE POPULATION SIZE; GENETIC EPISTASIS; GENETIC VARIABILITY; GENOME ANALYSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MOLECULAR EVOLUTION; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; STRAIN IDENTIFICATION; VIRAL GENETICS; VIRUS RECOMBINATION; VIRUS VIRULENCE; BIOLOGICAL MODEL; GENETIC RECOMBINATION; GENETICS; VIROLOGY;

HUMAN IMMUNODEFICIENCY VIRUS;

COMPUTER SIMULATION; EVOLUTION, MOLECULAR; HIV; HIV INFECTIONS; HUMANS; MODELS, GENETIC; RECOMBINATION, GENETIC; VARIATION (GENETICS);

EID: 45949105749     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.83668-0     Document Type: Article

References (61)

1. Achaz, G., Palmer, S., Kearney, M., Maldarelli, F., Mellors, J. W., Coffin, J. M. & Wakeley, J. (2004). A robust measure of HIV-1 population turnover within chronically infected individuals. Mol Biol Evol 21, 1902-1912.
2. Althaus, C. L & Bonhoeffer, S. (2005). Stochastic interplay between mutation and recombination during the acquisition of drug resistance mutations in human immunodeficiency virus type 1. J Virol 79, 13572-13578.
3. Barouch, D. H., Kunstman, J., Kuroda, M. J., Schmitz, J. E., Santra, S., Peyerl, F. W., Krivulka, G. R., Beaudry, K., Lifton, M. A. & other authors (2002). Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes. Nature 415, 335-339.
4. Blackard, J. T., Cohen, D. E. & Mayer, K H. (2002). Human immunodeficiency virus superinfection and recombination: current state of knowledge and potential clinical consequences. Clin Infect Dis 34, 1108-1114.
5. Bocharov, G., Ford, N. J., Edwards, J., Breinig, T., Wain-Hobson, S. & Meyerhans, A. (2005). A genetic-algorithm approach to simulating human immunodeficiency virus evolution reveals the strong impact of multiply infected cells and recombination. J Gen Virol 86, 3109-3118.
6. Bonhoeffer, S., Chappey, C., Parkin, N. T., Whitcomb, J. M. & Petropoulos, C. J. (2004). Evidence for positive epistasis in HIV-1. Science 306, 1547-1550.
7. Bretscher, M. T., Althaus, C. L., Muller, V. & Bonhoeffer, S. (2004). Recombination in HIV and the evolution of drug resistance: for better or for worse? Bioessays 26, 180-188.
8. Brown, A. J. L. (1997). Analysis of HIV-1 env gene sequences reveals evidence for a low effective number in the viral population. Proc Natl Acad Sci U S A 94, 1862-1865.
9. Charpentier, C., Nora, T., Tenaillon, O., Clavel, F. & Hance, A. J. (2006). Extensive recombination among human immunodeficiency virus type 1 quasispecies makes an important contribution to viral diversity in individual patients. J Virol 80, 2472-2482.
10. Chen, J., Dang, Q., Unutmaz, D., Pathak, V. K., Maldarelli, F., Powell, D. & Hu, W.-S. (2005). Mechanisms of nonrandom human immunodeficiency virus type 1 infection and double infection: preference in virus entry is important but is not the sole factor. J Virol 79, 4140-4149.
11. Christiansen, F. B., Otto, S. P., Bergman, A. & Feldman, M. W. (1998). Waiting with and without recombination: the time to production of a double mutant. Theor Popul Biol 53, 199-215.
12. Clavel, F. & Hance, A. J. (2004). Medical progress: HIV drug resistance. N Engl J Med 350, 1023-1035.
13. Dang, Q., Chen, J., Unutmaz, D., Coffin, J. M., Pathak, V. K., Powell, D., KewalRamani, V. N., Maldarelli, F. & Hu, W.-S. (2004). Nonrandom HIV-1 infection and double infection via direct and cell-mediated pathways. Proc Natl Acad Sci U S A 101, 632-637.
14. + cell turnover. Nature 375, 194-195.
15. Dimitrov, D. S., Willey, R. L., Sato, H., Chang, L J., Blumenthal, R. & Markin, M. A. (1993). Quantitation of human immunodeficiency virus type 1 infection kinetics. J Virol 67, 2182-2190.
16. Dixit, N. M., Markowitz, M., Ho, D. D. & Perelson, A. S. (2004). Estimates of intracellular delay and average drug efficacy from viral load data of HIV-infected individuals under antiretroviral therapy. Antivir Ther 9, 237-246.
17. Eshel, I. & Feldman, M. W. (1970). On the evolutionary effect of recombination. Theor Popul Biol 1, 88-100.
18. Ewens, W. J. (2004). Mathematical Population Genetics. New York, Springer.
19. Fraser, C. (2005). HIV recombination: what is the impact on antiretroviral therapy? J R Soc Interface 2, 489-503.
20. Frost, S. D. W., Nijhuis, M., Schuurman, R., Boucher, C. A. B. & Brown, A. J. L. (2000). Evolution of lamivudine resistance in human immunodeficiency virus type 1-infecled individuals: the relative roles of drift and selection. J Virol 74, 6262-6268.
21. Frost S. D. W., Dumaurier, M. J., Wain-Hobson, S. & Brown, A. J. L (2001). Genetic drift and within-host metapopulation dynamics of HIV-1 infection. Proc Natl Acad Sci U S A 98, 6975-6980.
22. Haase, A. T., Henry, K., Zupancic, M., Sedgewick, G., Faust, R. A., Melroe, H., Cavert, W., Gebhard, K., Staskus, K. & other authors (1996). Quantitative image analysis of HIV-1 infection in lymphoid tissue. Science 274, 985-989.
23. Hartl, D. L. & Clark, A. G. (2007). Principles of Population Genetics. Sunderland, MA: Sinauer Associates.
24. Herbeck, J. T., Nickle, D. C., Learn, G. H., Gottlieb, G. S., Curlin, M. E., Heath, L. & Mullins, J. I. (2006). Human immunodeficiency virus type 1 env evolves toward ancestral states upon transmission to a new host. J Virol 80, 1637-1644.
25. Hill, W. G. & Robertson, A. (1966). Effect of linkage on limits to artificial selection. Genet Res 8, 269-294.
26. Hockett, R. D., Kilby, J. M., Derdeyn, C. A., Saag, M. S., Sillers, M., Squires, K., Chiz, S., Nowak, M. A., Shaw, G. M. & Bucy, R. P. (1999). Constant mean viral copy number per infected cell in tissues regardless of high, low, or undetectable plasma HIV RNA. J Exp Med 189, 1545-1554.
27. Jetzt, A. E., Yu, H., Klarmann, G. J., Ron, Y., Preston, B. D. & Dougherty, J. P. (2000). High rate of recombination throughout the human immunodeficiency virus type 1 genome. J Virol 74, 1234-1240.
28. Jung, A., Maier, R., Vartanian, J. P., Bocharov, G., Jung, V., Fischer, U., Meese, E., Wain-Hobson, S. & Meyerhans, A. (2002). Multiply infected spleen cells in HIV patients. Nature 418, 144.
29. Kellam, P. & Larder, B. A. (1995). Retroviral recombination can lead to linkage of reverse-transcriptase mutations that confer increased zidovudine resistance. J Virol 69, 669-674.
30. Kils-Hutten, L., Cheynier, R., Wain-Hobson, S. & Meyerhans, A. (2001). Phylogenetic reconstruction of intrapatient evolution of human immunodeficiency virus type 1: predominance of drift and purifying selection. J Gen Virol 82, 1621-1627.
31. Kimura, M. (1980). A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences. J Mol Evol 16, 111-120.
32. Kouyos, R. D., Althaus, C. L. & Bonhoeffer, S. (2006a). Stochastic or deterministic: what is the effective population size of HIV-1? Trends Microbiol 14, 507-511.
33. Kouyos, R. D., Otto, S. P. & Bonhoeffer, S. (2006b). Effect of varying epistasis on the evolution of recombination. Genetics 173, 589-597.
34. Kouyos, R. D., Silander, O. K. & Bonhoeffer, S. (2007). Epistasis between deleterious mutations and the evolution of recombination. Trends Ecol Evol 22, 308-315.
35. Lech, W. J., Wang, G., Yang, Y. L., Chee, Y., Dorman, K., McCrae, D., Lazzeroni, L. C., Erickson, J. W., Sinsheimer, J. S. & Kaplan, A. H. (1996). In vivo sequence diversity of the protease of human immunodeficiency virus type 1: presence of protease inhibitor-resistant variants in untreated subjects. J Virol 70, 2038-2043.
36. Levy, D. N., Aldrovandi, G. M., Kutsch, O. & Shaw, G. M. (2004). Dynamics of HIV-1 recombination in its natural target cells. Proc Natl Acad Sci U S A 101, 4204-4209.
37. Mansky, L. M. & Temin, H. M. (1995). Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse-transcriptase. J Virol 69, 5087-5094.
38. Markham, R. B., Wang, W. C., Weisstein, A. E., Wang, Z., Munoz, A., Templeton, A., Margolick, J., Vlahov, D., Quinn, T. & other authors (1998). Patterns of HIV-1 evolution in individuals with differing rates of CD4 T cell decline. Proc Natl Acad Sci U S A 95, 12568-12573.
39. Markowitz, M., Louie, M., Hurley, A., Sun, E. & Di Mascio, M. (2003). A novel antiviral intervention results in more accurate assessment of human immunodeficiency virus type 1 replication dynamics and T-cell decay in vivo. J Virol 77, 5037-5038.
40. Moutouh, L., Corbeil, J. & Richman, D. D. (1996). Recombination leads to the rapid emergence of HIV-1 dually resistant mutants under selective drug pressure. Proc Natl Acad Sci U S A 93, 6106-6111.
41. Nijhuis, M., Boucher, C. A. B., Schipper, P., Leitner, T., Schuurman, R. & Albert, J. (1998). Stochastic processes strongly influence HIV-1 evolution during suboptimal protease-inhibitor therapy. Proc Natl Acad Sci U S A 95, 14441-14446.
42. Otto, S. P. & Barton, N. H. (2001). Selection for recombination in small populations. Evolution 55, 1921-1931.
43. Otto, S. P. & Lenormand, T. (2002). Resolving the paradox of sex and recombination. Nat Rev Genet 3, 252-261.
44. Perelson, A. S., Neumann, A. U., Markowitz, M., Leonard, J. M. & Ho, D. D. (1996). HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science 271, 1582-1586.
45. Piatak, M., Saag, M. S., Yang, L. C., Clark, S. J., Kappes, J. C., Luk, K C., Hahn, B. H., Shaw, G. M. & Lifson, J. D. (1993). High-levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 259, 1749-1754.
46. Rhodes, T., Wargo, H. & Hu, W.-S. (2003). High rates of human immunodeficiency virus type 1 recombination; near-random segregation of markers one kilobase apart in one round of viral replication. J Virol 77, 11193-11200.
47. Ribeiro, R. M. & Bonhoeffer, S. (2000). Production of resistant HIV mutants during antiretroviral therapy. Proc Natl Acad Sci U S A 97, 7681-7686.
48. Rice, W. R. (2002). Experimental tests of the adaptive significance of sexual recombination. Nat Rev Genet 3, 241-251.
49. Rodrigo, A. G., Shpaer, E. G., Delwart, E. L, Iversen, A. K. N., Gallo, M. V., Brojatsch, J., Hirsch, M. S., Walker, B. D. & Mullins, J. I. (1999). Coalescent estimates of HIV-1 generation time in vivo. Proc Natl Acad Sci U S A 96, 2187-2191.
50. Rouzine, I. M. & Coffin, J. M. (1999). Linkage disequilibrium test implies a large effective population number for HIV in vivo. Proc Natl Acad Sci U S A 96, 10758-10763.
51. Rouzine, I. M. & Coffin, J. M. (2005). Evolution of human immunodeficiency virus under selection and weak recombination. Genetics 170, 7-18.
52. Rouzine, I. M., Rodrigo, A. & Coffin, J. M. (2001). Transition between stochastic evolution and deterministic evolution in the presence of selection: general theory and application to virology. Microbiol Mol Biol Rev 65, 151-185.
53. Seo, T.-K., Thorne, J. L., Hasegawa, M. & Kishino, H. (2002). Estimation of effective population size of HIV-1 within a host: a pseudomaximum-likelihood approach. Genetics 160, 1283-1293.
54. Shankarappa, R., Margolick, J. B., Gange, S. J., Rodrigo, A. G., Upchurch, D., Farzadegan, H., Gupta, P., Rinaldo, C. R., Learn, G. H. & other authors (1999). Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infection. J Virol 73, 10489-10502.
55. Shriner, D, Rodrigo, A. G., Nickle, D. C. & Mullins, J. I. (2004a). Pervasive genomic recombination of HIV-1 in vivo. Genetics 167, 1573-1583.
56. Shriner, D., Shankarappa, R., Jensen, M. A., Nickle, D. C., Mittler, J. E., Margolick, J. B. & Mullins, J. I. (2004b). Influence of random genetic drift on human immunodeficiency virus type I env evolution during chronic infection. Genetics 166, 1155-1164.
57. Simon, V., Ho, D. D. & Karim, a A. (2006). HIV/AIDS epidemiology, pathogenesis, prevention, and treatment. Lancet 368, 489-504.
58. Suryavanshi, G. W. & Dixit, N. M. (2007). Emergence of recombinant forms of HIV: dynamics and scaling. PLoS Comput Biol 3, e205.
59. Thomson, M. M., Perez-Alvarez, L. & Najera, R. (2002). Molecular epidemiology of HIV-1 genetic forms and its significance for vaccine development and therapy. Lancet Infect Dis 2, 461-471.
60. Williamson, S., Perry, S. M., Bustamante, C. D., Orive, M. E, Stearns, M. N. & Kelly, J. K. (2005). A statistical characterization of consistent patterns of human immunodeficiency virus evolution within infected patients. Mol Biol Evol 22, 456-468.
61. Yuste, E, Moya, A. & Lopez-Galindez, C. (2002). Frequency-dependent selection in human immunodeficiency virus type 1. J Gen Virol 83, 103-106.